All Articles by Author:

Bob

RFX2 Promotes Tumor Cell Stemness through Epigenetic Regulation of PAF1 in Spinal Ependymoma

[Journal of Neuro-Oncology] The authors investigated the molecular mechanism that induce stem cell features in spinal ependymoma (SE). They found that RFX2 activates PAF1 transcription, which promoted tumor stemness of SE cells and led to the malignant progression of SE.

Biomarkers and Targeted Therapy for Cancer Stem Cells

[Trends In Pharmacological Sciences] Scientists provide an overview of the unique signaling and metabolic pathways of CSCs, summarize existing CSC biomarkers and CSC-targeted therapies, and discuss strategies to further differentiate CSCs from non-stem cancer cells.

BMP Signaling in Cancer Stemness and Differentiation

[Cell Regeneration] The authors provide a concise overview that highlights the diverse roles of the bone morphogenetic protein (BMP) signaling in various types of cancers.

Single-Organoid Analysis Reveals Clinically Relevant Treatment-Resistant and Invasive Subclones in Pancreatic Cancer

[NPJ Precision Oncology] Investigators comprehensively unraveled the intra-patient response heterogeneity and intrinsic aggressive nature of PDAC on bulk and single-organoid resolution.

SMAD4 Endows TGF-β1-Induced Highly Invasive Tumor Cells with Ferroptosis Vulnerability in Pancreatic Cancer

[Acta Pharmacologica Sinica] The authors showed that SMAD4 status almost determined the orientation of transforming growth factor β1 (TGF-β1)-induced epithelial-mesenchymal transition via the SMAD4-dependent canonical pathway in PDAC, which altered ferroptosis vulnerability.

BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1

[Advanced Science] Researchers highlighted the important roles of basic helix-loop-helix transcription factor 40 (BHLHE40)-mediated lipid peroxidation in inducing ferroptosis in pancreatic cancer (PCa) cells and provided a novel mechanism underlying sterol regulatory element-binding factor 1 (SREBF1) overexpression in PCa.

Popular

Survival Outcomes of Apalutamide as a Starting Treatment: Impact in Real-World Patients With Metastatic Hormone Sensitive Prostate Cancer (OASIS)

[Prostate Cancer and Prostatic Diseases] Scientists evaluated the impact of upfront therapy for metastatic hormone-sensitive prostate cancer on outcomes in real-world clinical practice in the United States.

A TBX2-Driven Signaling Switch From Androgen Receptor to Glucocorticoid Receptor Confers Therapeutic Resistance in Prostate Cancer

[Oncogene] Using human prostate cancer and CRPC cell line models, scientists demonstrated that TBX2 downregulated androgen receptor and upregulated glucocorticoid receptor through direct transcriptional regulation.

Radiotherapy-Resistant Prostate Cancer Cells Escape Immune Checkpoint Blockade through the Senescence-Related Ataxia Telangiectasia and Rad3-Related Protein

[Cancer Communications] Scientists identified a subset of prostate cancer cells that exhibited resistance to radiotherapy, characterized by a reduced antigen presentation capability, which enhanced their ability to evade immune detection and resist cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) blockade.